748 related articles for article (PubMed ID: 17010055)
1. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Br J Cancer; 2005 Mar; 92(5):857-66. PubMed ID: 15756256
[TBL] [Abstract][Full Text] [Related]
3. Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
Henningson M; Bågeman E; Sandberg T; Borg A; Olsson H; Jernström H
Fam Cancer; 2007; 6(4):445-52. PubMed ID: 17484040
[TBL] [Abstract][Full Text] [Related]
4. Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
Jernström H; Sellberg G; Borg A; Olsson H
Eur J Cancer Prev; 2006 Jun; 15(3):233-41. PubMed ID: 16679866
[TBL] [Abstract][Full Text] [Related]
5. IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
Henningson M; Hietala M; Törngren T; Olsson H; Jernström H
Fam Cancer; 2011 Jun; 10(2):173-85. PubMed ID: 21113804
[TBL] [Abstract][Full Text] [Related]
6. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
Henningson M; Johansson U; Borg A; Olsson H; Jernström H
Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA
Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840
[TBL] [Abstract][Full Text] [Related]
8. High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.
Jernström H; Borg K; Olsson H
Mol Genet Metab; 2005; 86(1-2):320-7. PubMed ID: 16084122
[TBL] [Abstract][Full Text] [Related]
9. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
[TBL] [Abstract][Full Text] [Related]
10. Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.
Bågeman E; Ingvar C; Rose C; Jernström H
Br J Cancer; 2007 Mar; 96(5):712-7. PubMed ID: 17311016
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.
Figer A; Karasik YP; Baruch RG; Chetrit A; Papa MZ; Sade RB; Rizel S; Friedman E
Isr Med Assoc J; 2002 Oct; 4(10):759-62. PubMed ID: 12389335
[TBL] [Abstract][Full Text] [Related]
12. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
[TBL] [Abstract][Full Text] [Related]
13. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
[TBL] [Abstract][Full Text] [Related]
14. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.
Kim J; Johnson L; Skrzynia C; Buchanan A; Gracia C; Mersereau JE
Cancer Causes Control; 2015 Aug; 26(8):1087-92. PubMed ID: 26006218
[TBL] [Abstract][Full Text] [Related]
16. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
Hudelist G; Wagner T; Rosner M; Fink-Retter A; Gschwantler-Kaulich D; Czerwenka K; Kroiss R; Tea M; Pischinger K; Köstler WJ; Attems J; Mueller R; Blaukopf C; Kubista E; Hengstschläger M; Singer CF
Endocr Relat Cancer; 2007 Dec; 14(4):1053-62. PubMed ID: 18045956
[TBL] [Abstract][Full Text] [Related]
18. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.
Antoniou AC; Rookus M; Andrieu N; Brohet R; Chang-Claude J; Peock S; Cook M; Evans DG; Eeles R; ; Nogues C; Faivre L; Gesta P; ; van Leeuwen FE; Ausems MG; Osorio A; ; Caldes T; Simard J; Lubinski J; Gerdes AM; Olah E; Fürhauser C; Olsson H; Arver B; Radice P; Easton DF; Goldgar DE
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):601-10. PubMed ID: 19190154
[TBL] [Abstract][Full Text] [Related]
19. Reproductive factors in hereditary breast cancer.
Jernström HC; Johannsson OT; Loman N; Borg A; Olsson H
Breast Cancer Res Treat; 1999 Dec; 58(3):295-301. PubMed ID: 10718491
[TBL] [Abstract][Full Text] [Related]
20. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
